Endomed s.r.o.

At Endomed s.r.o. in Kosice, clinical research in Digestive System Diseases focuses mainly on inflammatory bowel disease, including Crohn’s disease, ulcerative colitis, coeliac disease, and related gastrointestinal disorders. The trials are designed to test new treatments, compare treatment options, and better understand how these conditions affect the digestive tract.

• Studies in Crohn’s disease and ulcerative colitis aimed at improving symptom control and long-term disease management
• Research on coeliac disease and eosinophilic esophagitis exploring immune-related gut inflammation and mucosal healing
• Clinical evaluation of new therapies for inflammatory bowel disease to measure remission, healing, and overall treatment effectiveness

Overall, this therapeutic area is centered on finding safer and more effective options for people living with chronic gastrointestinal inflammation and immune-driven digestive disorders.

The Immune System Diseases research portfolio at Endomed s.r.o. includes trials for conditions where the immune system drives ongoing inflammation, especially Crohn’s disease, ulcerative colitis, and eosinophilic esophagitis. These studies aim to improve how immune-targeted treatments work and to assess whether they can reduce inflammation and support lasting disease control.

• Trials in moderately to severely active Crohn’s disease assessing new immune-based therapies for remission and response
• Research in moderately to severely active ulcerative colitis focused on treatment effectiveness, maintenance of benefit, and symptom relief
• Studies in eosinophilic esophagitis and non-responsive celiac disease examining immune activity in the gut and esophagus

These projects reflect a strong emphasis on immune-mediated disease, with the goal of advancing targeted approaches that may better match the needs of patients with chronic inflammatory conditions.